
Title: QC Senior Specialist, Quality Control Laboratory
Reports to: Director, Quality Laboratory
Location: Camarillo, CA
Classification: Exempt
This laboratory position will be in the Quality Control Department and support activities associated with routine in-process testing, Certificate of Analysis (COA) release testing, and stability program support for biologics. Person needs to have experience performing capillary electrophoresis testing (cIEF, CE-SDS). This position will demonstrate strong technical proficiency with various analytical methods, operate as a technical leader within the QC team, supporting complex testing, driving investigation quality, and ensuring compliant execution of analytical programs.
In addition, this position will oversee laboratory investigations, identify and implement CAPAs, and manage analytical method lifecycle activities including protocol drafting and execution of method validation, verification, and transfer in accordance with regulatory expectations.
Responsibilities & Duties
Qualifications:
The Base Salary Range for this position is $115,000 to $145,000. Coherus considers various factors, including professional background and work experience, when determining base pay. These considerations mean actual compensation will vary.
Coherus provides equal employment opportunities to all employees and applicants for employment and prohibits unlawful discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws. We also prohibit discrimination based on the perception that anyone has any of these characteristics or is associated with a person who has or is perceived as having any of these characteristics.

Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents.
If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.